Kamada Pharmaceuticals vs Travere Therapeutics
Kamada Pharmaceuticals vs Travere Therapeutics, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Kamada Pharmaceuticals is on 50/100 and Travere Therapeutics on 51/100.
Where each one leads
Kamada Pharmaceuticals
- funding raised: $150M against $63.0M
Travere Therapeutics
- domain rating: 58/100 against 49/100
At a glance
| Measure | Kamada Pharmaceuticals | Travere Therapeutics |
|---|---|---|
| What it is | Global biopharmaceutical company specializing in plasma-derived therapeutics for rare and serious conditions. | A biopharmaceutical company focused on developing and commercializing therapies for rare diseases. |
| Category | Biopharma, Plasma-derived therapeutics, Orphan diseases, Immunology | Biotechnology, Pharmaceuticals, Healthcare, Rare Diseases |
| Sells toBusiness model | B2B | B2B |
| Offering | Pharmaceuticals | Services |
| Founded | 1990 | 2015 |
| Headquarters | Rehovot, Israel | San Diego, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | Kamada Pharmaceuticals | Travere Therapeutics |
|---|---|---|
| Employees | Not published | 125 |
| Total funding | $150M | $63.0M |
| Latest round | Not published | Convertible Note |
| Valuation | Not published | $1.1B |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Kamada Pharmaceuticals | Travere Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 50/100 | 51/100 |
| Traction | 40/100 | 59/100 |
| Team | 70/100 | 50/100 |
| Search visibility | 14/100 | 5/100 |
| Quality | 58/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 49/100 | 58/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Kamada Pharmaceuticals | Travere Therapeutics |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | WordPress | WordPress |
| Frameworks | Jquery | Jquery, Tailwind CSS |
| Analytics | Not detected | Google Tag Manager, Linkedin Insight |
Kamada Pharmaceuticals vs Travere Therapeutics: common questions
Which is better, Kamada Pharmaceuticals or Travere Therapeutics?
On our 0-100 score Travere Therapeutics rates higher (51/100 against 50/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do Kamada Pharmaceuticals and Travere Therapeutics compare on the numbers?
Kamada Pharmaceuticals leads on funding raised ($150M against $63.0M). Travere Therapeutics leads on domain rating (58/100 against 49/100).
Read the full Kamada Pharmaceuticals review and pricing or the Travere Therapeutics review and pricing. You can also browse other Kamada Pharmaceuticals alternatives we track.